Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes

被引：0
|
作者：
Kassab, Y. W. [1 ]
AbdulRazzaq, H. A. [1 ]
Altaie, A. H. [2 ]
Hassan, Y. [3 ]
Abd Aziz, N. [3 ]
Najjar, M. F. [4 ]
Ismail, O. [5 ]
机构：
[1] Univ Sci Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Ankara Univ, Tomer Inst, TR-06100 Ankara, Turkey
[3] Univ Teknol MARA, Fac Pharm, Kuala Lumpur, Malaysia
[4] King Abdullah Int Med Res Ctr, Dept Clin Pharm, Riyadh, Saudi Arabia
[5] Hosp Pulau Pinang, Dept Cardiol, George Town, Malaysia
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2013年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：911 / 911
页数：1
相关论文
共 50 条
  • [21] Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review
    Bahit, M. Cecilia
    Korjian, Serge
    Daaboul, Yazan
    Baron, Suzanne
    Bhatt, Deepak L.
    Kalayci, Arzu
    Chi, Gerald
    Nara, Paul
    Shaunik, Alka
    Gibson, C. Michael
    CLINICAL THERAPEUTICS, 2023, 45 (11) : 1119 - 1126
  • [22] Trajectories of Ticagrelor Adherence in Patients With Acute Coronary Syndromes
    Moon, Jungyeon
    Ozaki, Aya
    Ko, Dennis T.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Sud, Maneesh
    Jackevicius, Cynthia
    CIRCULATION, 2022, 146
  • [23] Secondary prevention of acute coronary syndromes: are we disregarding the guidelines?
    Casella, Gianni
    Greco, Cesare
    Maggioni, Aldo P.
    Di Pasquale, Giuseppe
    GIORNALE ITALIANO DI CARDIOLOGIA, 2006, 7 (03) : 176 - 185
  • [24] GRACE scores in COPD patients with acute coronary syndromes: Performance and impact on secondary prevention
    Rothnie, Kieran
    Smeeth, Liam
    Herrett, Emily
    Pearce, Neil
    Hemingway, Harry
    Wedzicha, Jadwiga
    Timmis, Adam
    Quint, Jennifer
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] USE OF SECONDARY PREVENTION MEDICATIONS AMONG PATIENTS WITH ACUTE CORONARY SYNDROMES IN TIANJIN, CHINA
    Wang, Y.
    Cong, H.
    Lu, C.
    Liu, J.
    Wu, J.
    VALUE IN HEALTH, 2017, 20 (05) : A276 - A277
  • [26] The Potential Role of Prasugrel in Secondary Prevention of Ischemic Events in Patients with Acute Coronary Syndromes
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2009, 121 (01) : 59 - 72
  • [27] Predictors of adherence to composite therapy after acute coronary syndromes
    Stabile, Eugenio
    Franzese, Michele
    Chianese, Salvatore
    Alfani, Arturo
    Gerardi, Donato
    Colaiori, Iginio
    Annunziata, Monica
    Nappi, Pierluigi
    Scalise, Martina
    Di Serafino, Luigi
    Puzone, Brunella
    Avvedimento, Marisa
    Leone, Attilio
    Ilardi, Federica
    Piccolo, Raffaele
    Franzone, Anna
    Cirillo, Plinio
    Morisco, Carmine
    Trimarco, Bruno
    Esposito, Giovanni
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (08) : 645 - 651
  • [28] Adherence to secondary prevention therapies following acute coronary syndromes: One-year results from the Canadian acute coronary syndrome registry
    Yan, AT
    Goodman, SG
    Tan, M
    Fitchett, D
    Chow, CM
    Langer, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 382A - 383A
  • [29] Trends in adherence to secondary prevention medications in post-acute coronary syndrome patients
    Kassab, Yaman Walid
    Hassan, Yahaya
    Abd Aziz, Noorizan
    Zulkifly, Hanis Hanum
    Iqbal, Muhammad Shahid
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (02) : 641 - 646
  • [30] Evaluation of pharmacotherapy use in secondary prevention for patients with coronary heart disease one year after coronary angiography
    Kreicburga, L
    Latkovskis, G
    Kalnins, U
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (04) : 24 - 24
12345